Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis

Published:2021-03 Issue:3 Volume:61 Page:422-429
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Blumenfeld Andrew M.¹,Goadsby Peter J.²³,Dodick David W.⁴,Hutchinson Susan⁵^ORCID,Liu Chengcheng⁶,Finnegan Michelle⁶,Trugman Joel M.⁶,Szegedi Armin⁶

Affiliation:

1. The Neurology Center Headache Center of Southern California Carlsbad CA USA

2. NIHR‐Wellcome Trust King's Clinical Research Facility King's College London UK

3. University of California Los Angeles CA USA

4. Department of Neurology Mayo Clinic Phoenix AZ USA

5. Department of Headache Orange County Migraine and Headache Center Irvine CA USA

6. AbbVie Madison NJ USA

Funder

Allergan

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/head.14089

Reference27 articles.

1. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies

2. Migraine prevalence, disease burden, and the need for preventive therapy

3. Satisfaction With Current Migraine Therapy: Experience From 3 Centers in US and Sweden

4. Examination of Unmet Treatment Needs Among Persons With Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study

5. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study;Cephalalgia;2024-09

2. Revolutionizing migraine management: advances and challenges in CGRP-targeted therapies and their clinical implications;Frontiers in Neurology;2024-06-13

3. New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication;Cephalalgia;2024-03

4. Towards precision medicine in migraine: Recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response;Pharmacology & Therapeutics;2023-10

5. Molecular Mechanisms of Migraine: Nitric Oxide Synthase and Neuropeptides;International Journal of Molecular Sciences;2023-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3